Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

ERYTHROMYCIN

ERYTHROMYCIN

Standard Dose
1.5%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ERYTHROMYCIN is listed in Drugs@FDA under application 062485 (ANDA).

Marketing status: Discontinued Active ingredient ERYTHROMYCIN Form and strength SOLUTION;TOPICAL - 1.5% Sponsor PHARMAFAIR Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview ERYTHROMYCIN is listed in Drugs@FDA under application 062485 (ANDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN Form and strength SOLUTION;TOPICAL - 1.5% Sponsor PHARMAFAIR Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.